Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Zyma Laboratories Limited, was an unlisted public company incorporated on 21 November, 1970. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital was INR 1.66 cr and the total paid-up capital was INR 1.38 cr.
The current status of Zyma Laboratories Limited is - Amalgamated.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
9.29%
7.69%
-68.97%
2.15%
6.23%
5.07%
5.57
-0.31
-8.37
-8.01
-0.76
0.01
No Reports Available
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Sunil Makharia | 00064399 | 13 years |
| Director | Manju Deshbandhu Gupta | 00209461 | 49 years |
| Director | Nilesh Deshbandhu Gupta | 01734642 | 20 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| ORGO MERCANTILE TRADERS PRIVATE LIMITED |
Amalgamated
|
1.0 L | 2 | Maharashtra |
| D. B. ESTATE TRADE PRIVATE LIMITED |
Amalgamated
|
1.0 L | 2 | Maharashtra |
| RAHAS MULTITRADE PRIVATE LIMITED |
Amalgamated
|
1.0 L | 2 | Maharashtra |
| BS MERC PRIVATE LIMITED |
Amalgamated
|
1.0 L | 2 | Maharashtra |
| ZYMA PROPERTIES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| LUPIN HERBAL LIMITED |
Amalgamated
|
5.0 L | 1 | Maharashtra |
| LUPIN HOLDINGS PRIVATE LIMITED |
Amalgamated
|
13.8 Cr | 2 | Maharashtra |
| NOVAMED INVESTMENTS PRIVATE LIMITED |
Amalgamated
|
9.5 Cr | 2 | Maharashtra |
| LUPIN INTERNATIONAL PRIVATE LIMITED |
Amalgamated
|
5.0 L | 3 | Maharashtra |
| ZUARI LEATHERS PRIVATE LIMITED |
Amalgamated
|
15.5 L | 1 | Maharashtra |
| VISIOMED INVESTMENTS PRIVATE LIMITED |
Amalgamated
|
11.9 Cr | 2 | Maharashtra |
| RAHAS INVESTMENTS PRIVATE LIMITED |
Amalgamated
|
13.8 Cr | 3 | Maharashtra |
| SYNCHEM INVESTMENTS PRIVATE LIMITED |
Amalgamated
|
82.5 Cr | 2 | Maharashtra |
| NOVEL CLINICAL RESEARCH (INDIA) PRIVATE LIMITED |
Strike Off
|
1.0 L | 2 | Karnataka |
| ELEMENT119 LEASING AND FINANCE PRIVATE LIMITED |
Dissolved
|
2.0 Cr | 3 | Maharashtra |
| SAMIKSH INVESTMENT PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Maharashtra |
| GOODYEAR INVESTMENT P. LTD |
Amalgamated
|
1.0 L | 1 | Maharashtra |
| CROP TECH CHEMICALS (INDIA) PRIVATE LIMITED |
Dissolved
|
1.0 Cr | 2 | Maharashtra |
| LUPIN PROPERTIES LIMITED |
Amalgamated
|
5.2 L | 3 | Maharashtra |
| RAHAS MERCANTILE PRIVATE LIMITED |
Amalgamated
|
108.0 Cr | 2 | Maharashtra |
| SYNCHEM PROPERTIES PRIVATE LIMITED |
Active
|
11.0 Cr | 2 | Maharashtra |
| VISIOMED INVESTMENTS PRIVATE LIMITED |
Active
|
5.0 Cr | 3 | Maharashtra |
| LUPIN ATHARV ABILITY LIMITED |
Active
|
10.0 L | 2 | Maharashtra |
| LUPIN INVESTMENTS PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| POLYNOVA INDUSTRIES LIMITED |
Active
|
23.0 Cr | 2 | Maharashtra |
| LUPIN DIGITAL HEALTH LIMITED |
Active
|
62.3 Cr | 2 | Maharashtra |
| LUPIN DIAGNOSTICS LIMITED |
Active
|
202.6 Cr | 3 | Maharashtra |
| LUPIN LIMITED |
Active
|
91.2 Cr | 2 | Maharashtra |
| NOVODIGM LIMITED |
Amalgamated
|
2.4 Cr | 1 | Gujarat |
| LUPIN PHARMACARE LIMITED |
Amalgamated
|
1.1 Cr | 1 | Maharashtra |
| LUPIN BIOLOGICS LIMITED |
Active
|
15.0 L | 1 | Maharashtra |
| LUPIN MANUFACTURING SOLUTIONS LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
The incorporation date of ZYMA LABORATORIES LIMITED is 21 November, 1970
The authorized share capital of ZYMA LABORATORIES LIMITED is INR ₹ 1.7 Cr.
The paid-up capital of ZYMA LABORATORIES LIMITED is INR ₹ 1.4 Cr.
The registered address of ZYMA LABORATORIES LIMITED is 159 CST ROAD. KALINA SANTACRUZ EAST MUMBAI Maharashtra - 400098
The CIN number of ZYMA LABORATORIES LIMITED is U24230MH1970PLC014881.
Expand
Delete
Collapse
See
details
